Cas:1037147-97-9 ethyl 2-(4-fluorophenyl)sulfonylacetate manufacturer & supplier

We serve Chemical Name:ethyl 2-(4-fluorophenyl)sulfonylacetate CAS:1037147-97-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 2-(4-fluorophenyl)sulfonylacetate

Chemical Name:ethyl 2-(4-fluorophenyl)sulfonylacetate
CAS.NO:1037147-97-9
Synonyms:2-[(4-fluorophenyl)sulfonyl]acetic acid ethyl ester
Molecular Formula:C10H11FO4S
Molecular Weight:246.25500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.306
Index of Refraction:
PSA:68.82000
Exact Mass:246.03600
LogP:2.24330

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-[(4-fluorophenyl)sulfonyl]acetic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[(4-fluorophenyl)sulfonyl]acetic acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[(4-fluorophenyl)sulfonyl]acetic acid ethyl ester Use and application,2-[(4-fluorophenyl)sulfonyl]acetic acid ethyl ester technical grade,usp/ep/jp grade.


Related News: Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY. Hypaconitine manufacturers in addition to standard therapy. The trial did not meet its primary endpoint based on the SLE Responder Index 4 (SRI4) composite measure. Sodium 2-dodecylbenzenesulfonate suppliers UK-headquartered Verona announced at the beginning of the year that it had completed enrolment in a pilot study evaluating the efficacy of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19. 2,4-Dichloro-6,7-dihydrothieno[3,2-d]pyrimidine vendor & factory.